UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 477

Sortiert nach

Phase I study of GRN1005 in recurrent malignant glioma

Clinical cancer research, 2013-03, Vol.19 (6), p.1567-1576

2013

Volltextzugriff (PDF)

Pharmacokinetics, Excretion, and Mass Balance of Liposomal Amphotericin B (AmBisome) and Amphotericin B Deoxycholate in Humans

Antimicrobial Agents and Chemotherapy, 2002-03, Vol.46 (3), p.828-833

2002

Volltextzugriff (PDF)

Plasma Protein Binding of Amphotericin B and Pharmacokinetics of Bound versus Unbound Amphotericin B after Administration of Intravenous Liposomal Amphotericin B (AmBisome) and Amphotericin B Deoxycholate

Antimicrobial Agents and Chemotherapy, 2002-03, Vol.46 (3), p.834-840

2002

Volltextzugriff (PDF)

Reversible Inhibitors of Monoamine Oxidase-A (RIMAs): Robust, Reversible Inhibition of Human Brain MAO-A by CX157

Neuropsychopharmacology (New York, N.Y.), 2010-02, Vol.35 (3), p.623-631

2010

Volltextzugriff (PDF)

2-hydroxyestradiol is a prodrug of 2-methoxyestradiol

The Journal of pharmacology and experimental therapeutics, 2004-06, Vol.309 (3), p.1093

2004

Volltextzugriff (PDF)

Lack of tyramine pressor response effect with oral CX157: A specific reversible MAOI

Clinical pharmacology in drug development, 2014-01, Vol.3 (1), p.4-12

2014

Volltextzugriff (PDF)

Pharmacokinetic study of Noni fruit extract

Journal of dietary supplements, 2008, Vol.5 (4), p.373-382

2008

Volltextzugriff (PDF)

Safety and toxicokinetics of intravenous liposomal amphotericin B (AmBisome®) in beagle dogs

Pharmaceutical research, 1999-11, Vol.16 (11), p.1694-1701

1999

Volltextzugriff (PDF)

Plasma and Red Blood Cell Membrane Accretion and Pharmacokinetics of RT001 (bis-Allylic 11,11-D2-Linoleic Acid Ethyl Ester) during Long Term Dosing in Patients

Journal of pharmaceutical sciences, 2020-11, Vol.109 (11), p.3496-3503

2020

Volltextzugriff (PDF)

Altered tissue distribution and elimination of amikacin encapsulated in unilamellar, low-clearance liposomes (MiKasome®)

Pharmaceutical research, 1998-11, Vol.15 (11), p.1775-1781

1998

Volltextzugriff (PDF)

Pharmacokinetics and Urinary Excretion of Amikacin in Low-Clearance Unilamellar Liposomes after a Single or Repeated Intravenous Administration in the Rhesus Monkey

Antimicrobial Agents and Chemotherapy, 1999-03, Vol.43 (3), p.503-509

1999

Volltextzugriff (PDF)

Recombinant Human Hemoglobin Inhibits Both Constitutive and Cytokine-Induced Nitric Oxide-Mediated Relaxation of Rabbit Isolated Aortic Rings

Journal of cardiovascular pharmacology, 1994-08, Vol.24 (2), p.229-237

1994

Volltextzugriff (PDF)

Pharmacokinetics, Excretion, and Mass Balance of 14C after Administration of 14C-Cholesterol-Labeled AmBisome to Healthy Volunteers

Journal of clinical pharmacology, 2001-09, Vol.41 (9), p.963-971

2001

Volltextzugriff (PDF)

A phase I trial of continuous infusion of the multidrug resistance inhibitor zosuquidar with daunorubicin and cytarabine in acute myeloid leukemia

Leukemia research, 2009-08, Vol.33 (8), p.1055-1061

2009

Volltextzugriff (PDF)

Lipid-based amphotericin B formulations: from animals to man

Pharmaceutical Science & Technology Today, 1999-06, Vol.2 (6), p.230-236

1999

Volltextzugriff (PDF)

Safety, toxicokinetics and tissue distribution of long-term intravenous liposomal amphotericin B (Ambisome®) : A 91-day study in Rats

Pharmaceutical research, 2000-12, Vol.17 (12), p.1494-1502

2000

Volltextzugriff (PDF)

Relationship of pharmacokinetically-calculated volumes of distribution to the physiologic distribution of liposomal drugs in tissues : Implications for the characterization of liposomal formulations

Pharmaceutical research, 2001-02, Vol.18 (2), p.238-242

FIELDING, Robert M

2001

Volltextzugriff (PDF)

Liposomal drug delivery : advantages and limitations from a clinical pharmacokinetic and therapeutic perspective

Clinical pharmacokinetics, 1991-09, Vol.21 (3), p.155-164

FIELDING, R. M

1991

Volltextzugriff (PDF)

Pharmacokinetics, excretion, and mass balance of (14)C after administration of (14)C-cholesterol-labeled AmBisome to healthy volunteers

Journal of clinical pharmacology, 2001-09, Vol.41 (9), p.963

2001

Volltextzugriff (PDF)

Query processing in a database mediation system

Fielding, Robert Wayne

1989

Volltextzugriff (PDF)

Novel antifungal drug delivery: stable amphotericin B-cholesteryl sulfate discs

International journal of pharmaceutics, 1991-08, Vol.75 (1), p.45-54

1991

Volltextzugriff (PDF)

Comparative tissue distribution and elimination of amphotericin B colloidal dispersion (Amphocil®) and Fungizone® after repeated dosing in rats

Pharmaceutical research, 1995-02, Vol.12 (2), p.275-283

1995

Volltextzugriff (PDF)

Pharmacokinetics, Excretion, and Mass Balance of 14 C after Administration of 14 C‐Cholesterol‐Labeled AmBisome to Healthy Volunteers

Journal of clinical pharmacology, 2001-09, Vol.41 (9), p.963-971

2001

Volltextzugriff (PDF)

Pharmacokinetics, Excretion, and Mass Balance of 14C after Administration of 14C-Cholesterol-Labeled AmBisome to Healthy Volunteers

Journal of clinical pharmacology, 2001-09, Vol.41 (9), p.963-971

2001

Volltextzugriff (PDF)

Factors affecting the release rate of terbutaline from liposome formulations after intratracheal instillation in the guinea pig

Pharmaceutical research, 1992-02, Vol.9 (2), p.220-223

1992

Volltextzugriff (PDF)

1 – 25 von 477

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(426)
Mit Volltextzugriff
(408)

Publikationsform

5 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(476)
Japanisch
(57)

Erscheinungsjahr

n.n

Thema

Science & Technology
(301)
Life Sciences & Biomedicine
(246)
Humans
(206)
Male
(117)
Female
(110)
Biological And Medical Sciences
(69)
Aged
(65)
Medical Sciences
(58)
Adult
(57)
General & Internal Medicine
(53)
Middle Aged
(50)
Medicine, General & Internal
(48)
Public, Environmental & Occupational Health
(48)
Physical Sciences
(44)
Aged, 80 And Over
(37)
Animals
(30)
United States
(29)
Geriatrics & Gerontology
(28)
Older People
(28)
Pharmacology & Pharmacy
(27)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Phase I study of GRN1005 in recurrent malignant glioma

Pharmacokinetics, Excretion, and Mass Balance of Liposomal Amphotericin B (AmBisome) and Amphotericin B Deoxycholate in Humans

Plasma Protein Binding of Amphotericin B and Pharmacokinetics of Bound versus Unbound Amphotericin B after Administration of Intravenous Liposomal Amphotericin B (AmBisome) and Amphotericin B Deoxycholate

Reversible Inhibitors of Monoamine Oxidase-A (RIMAs): Robust, Reversible Inhibition of Human Brain MAO-A by CX157

2-hydroxyestradiol is a prodrug of 2-methoxyestradiol

Lack of tyramine pressor response effect with oral CX157: A specific reversible MAOI

Pharmacokinetic study of Noni fruit extract

Safety and toxicokinetics of intravenous liposomal amphotericin B (AmBisome®) in beagle dogs

Plasma and Red Blood Cell Membrane Accretion and Pharmacokinetics of RT001 (bis-Allylic 11,11-D2-Linoleic Acid Ethyl Ester) during Long Term Dosing in Patients

Altered tissue distribution and elimination of amikacin encapsulated in unilamellar, low-clearance liposomes (MiKasome®)

Pharmacokinetics and Urinary Excretion of Amikacin in Low-Clearance Unilamellar Liposomes after a Single or Repeated Intravenous Administration in the Rhesus Monkey

Recombinant Human Hemoglobin Inhibits Both Constitutive and Cytokine-Induced Nitric Oxide-Mediated Relaxation of Rabbit Isolated Aortic Rings

Pharmacokinetics, Excretion, and Mass Balance of 14C after Administration of 14C-Cholesterol-Labeled AmBisome to Healthy Volunteers

A phase I trial of continuous infusion of the multidrug resistance inhibitor zosuquidar with daunorubicin and cytarabine in acute myeloid leukemia

Lipid-based amphotericin B formulations: from animals to man

Safety, toxicokinetics and tissue distribution of long-term intravenous liposomal amphotericin B (Ambisome®) : A 91-day study in Rats

Relationship of pharmacokinetically-calculated volumes of distribution to the physiologic distribution of liposomal drugs in tissues : Implications for the characterization of liposomal formulations

Liposomal drug delivery : advantages and limitations from a clinical pharmacokinetic and therapeutic perspective

Pharmacokinetics, excretion, and mass balance of (14)C after administration of (14)C-cholesterol-labeled AmBisome to healthy volunteers

Query processing in a database mediation system

Novel antifungal drug delivery: stable amphotericin B-cholesteryl sulfate discs

Comparative tissue distribution and elimination of amphotericin B colloidal dispersion (Amphocil®) and Fungizone® after repeated dosing in rats

Pharmacokinetics, Excretion, and Mass Balance of 14 C after Administration of 14 C‐Cholesterol‐Labeled AmBisome to Healthy Volunteers

Pharmacokinetics, Excretion, and Mass Balance of 14C after Administration of 14C-Cholesterol-Labeled AmBisome to Healthy Volunteers

Factors affecting the release rate of terbutaline from liposome formulations after intratracheal instillation in the guinea pig

Suchergebnisse filtern